{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:12:18Z","timestamp":1790194338868,"version":"4.1.0"},"reference-count":60,"publisher":"SAGE Publications","issue":"6-10","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicol Ind Health"],"published-print":{"date-parts":[[2004,7]]},"abstract":"<jats:p> 2-Mercaptobenzothiazole (MBT) is used as a vulcanization accelerator in rubber products that come into contact with potable drinking water. When such products are evaluated for contact with potable water and submitted for ANSI\/NSF Standard 61 certification, any chemical extracting from these products must be below an appropriate action level of exposure. As defined by Standard 61, a total allowable concentration (TAC) is the maximum concentration of a nonregulated contaminant allowed in a public drinking water supply, and the single product allowable concentration (SPAC) is 10% of the TAC. Currently, MBT has a TAC of 40 mg\/L and a SPAC of 4 mg\/L. A comprehensive health effects evaluation of MBT was performed to determine whether these action levels should be revised. Epidemiological investigations indicate that workers occupationally exposed to MBT have an increased risk of death from bladder cancer. Genotoxicity investigations in bacterial and mammalian test systems provide some evidence indicating that MBT has the potential to induce mutations and chromosomal aberrations. Toxicity studies in rats and mice chronically exposed to MBT identified increases in various tumours, such as adrenal gland tumours, pituitary gland tumours, liver tumours and renal pelvis tumours. The biological significance of most of these tumours is questionable due to a variety of factors, such as a lack of dose-response between tumour incidence and dose, and the effect of test article vehicle (corn oil) upon tumour rates. Potential human health effects of exposure to MBT can be predicted from an NTP 2-year cancer study in rats, as well as epidemiological investigations in occupationally exposed workers. A comprehensive review of the epidemiological and toxicological dataset for MBT indicates that the induction of renal pelvis transitional cell tumours is the most sensitive and relevant health effects endpoint upon which to base a revised TAC and SPAC. A multistage model was used to extrapolate to low-dose MBT exposures due to the genotoxicity and clastogenicity of MBT. A TAC of 600 mg\/L was derived for MBT, and was based upon an LED<jats:sub>10<\/jats:sub> of 157.681 mg\/kg per day. A SPAC of 60 mg\/L was derived by multiplying the revised TAC by 0.10, and rounding to one significant figure. These revised action levels are based upon the most sensitive health effects endpoint, as well as current cancer risk assessment methodology. <\/jats:p>","DOI":"10.1191\/0748233704th199oa","type":"journal-article","created":{"date-parts":[[2005,4,21]],"date-time":"2005-04-21T06:22:26Z","timestamp":1114064546000},"page":"149-163","source":"Crossref","is-referenced-by-count":31,"title":["Human health risk assessment of 2-mercaptobenzothiazole in drinking water"],"prefix":"10.1177","volume":"20","author":[{"given":"Margaret H","family":"Whittaker","sequence":"first","affiliation":[{"name":"ToxServices LLC, Washington, DC, USA,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann Marie","family":"Gebhart","sequence":"additional","affiliation":[{"name":"Underwriters Laboratories, Northbrook, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thea Clipson","family":"Miller","sequence":"additional","affiliation":[{"name":"ToxServices LLC, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Hammer","sequence":"additional","affiliation":[{"name":"Underwriters Laboratories, Northbrook, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2004,7,1]]},"reference":[{"key":"atypb1","volume-title":"HPV Challenge Program submission benzothiazole-based thiazoles category","author":"American Chemistry Council (ACC)","year":"2001"},{"key":"atypb2","doi-asserted-by":"publisher","DOI":"10.1002\/em.2850160505"},{"key":"atypb3","unstructured":"Berufsgenossenschaft der chemischen Industrie (BUA GDCh Advisory Committee on Existing Chemicals). 2000: 2-Mercaptobenzothiazol. Number 70, www.gdch.de\/taetigkeiter\/bua\/berichte.htm (last accessed December 04)."},{"key":"atypb4","first-page":"252","volume":"31","author":"Bregman, C. L.","year":"2003","journal-title":"Toxicologic Pathology"},{"key":"atypb5","volume-title":"No significant risk level for the Proposition 65 carcinogen benzofuran","author":"California Environmental Protection Agency (Cal-EPA)","year":"2002"},{"key":"atypb6","volume-title":"Letter from Chemical Manufacturers Association to US EPA regarding information on the enclosed final reports on 2-mercaptobenzothiazole","author":"Chemical Manufacturers Association (CMA)","year":"1989"},{"key":"atypb7","doi-asserted-by":"publisher","DOI":"10.1136\/oem.56.10.667"},{"key":"atypb8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1999.tb06240.x"},{"key":"atypb9","first-page":"481","volume":"42","author":"Crebelli, R.","year":"1985","journal-title":"British Journal of Industrial Medicine"},{"key":"atypb10","first-page":"27","volume":"9","author":"Donner, M.","year":"1983","journal-title":"Scandinavian Journal of Work, Environment & Health"},{"key":"atypb11","doi-asserted-by":"publisher","DOI":"10.1080\/15287398909531279"},{"key":"atypb12","first-page":"103","volume-title":"Quantitative estimation and predication of human cancer risks","author":"Feron, V. J.","year":"1999"},{"key":"atypb13","doi-asserted-by":"publisher","DOI":"10.1007\/BF00661376"},{"key":"atypb14","unstructured":"Goodyear. 1980: Mutagenicity evaluation of Captax. Summarized in BUA, 2000."},{"key":"atypb15","first-page":"501","volume-title":"Pathology of the Fischer rat: reference and atlas","author":"Hamlin, M. H.","year":"1990"},{"key":"atypb16","first-page":"66","volume":"7","author":"Hardin, B. D.","year":"1981","journal-title":"Scandinavian Journal of Work, Environment & Health"},{"key":"atypb17","doi-asserted-by":"publisher","DOI":"10.1177\/019262339802600318"},{"key":"atypb18","unstructured":"Hazardous Substance Databank (HSDB). 2004: 2-Mercapto-benzothiazole on-line record http:\/\/toxnet.nlm.nih.gov\/cgi-bin\/sis\/htmlgen?HSDB (last accessed December 04)."},{"key":"atypb19","volume-title":"Epidemiology in medicine","author":"Hennekens, C. H.","year":"1987"},{"key":"atypb20","first-page":"1101","volume":"42","author":"Innes, J. R. M.","year":"1969","journal-title":"Journal of the National Cancer Institute"},{"key":"atypb21","first-page":"109","volume-title":"Pathology of the Fischer rat: reference and atlas","author":"Jokinen, M. P.","year":"1990"},{"key":"atypb22","first-page":"139","volume":"147","author":"La Vecchia, C.","year":"1999","journal-title":"IARC Scientific Publications"},{"key":"atypb23","volume-title":"Report to the Chemical Manufacturer\u2019s Association","author":"Litton","year":"1985"},{"key":"atypb24","first-page":"283","volume":"76","author":"McConnell, E.","year":"1986","journal-title":"Journal of the National Cancer Institute"},{"key":"atypb25","unstructured":"Monsanto. undated (a): Mouse lymphoma test report. Monsanto report BO-78-0240. Cited in ACC, 2001."},{"key":"atypb26","unstructured":"Monsanto. undated (b): Dominant lethal assay. Monsanto report SB-91-9705. SLS Study Number 3205. Springborn Laboratories Study No. 3205.5, 3205.6, 3205.7."},{"key":"atypb27","unstructured":"Monsanto. undated (c): Monsanto report SB-91-9708. Jointly sponsored through the Chemical Manufacturer\u2019s Association as part of a TSCA Section 4 test rule. Summarized in ACC, 2001."},{"key":"atypb28","unstructured":"Monsanto. undated (d): Monsanto report SB-91-9702. Jointly sponsored through the Chemical Manufacturer\u2019s Association as part of a TSCA Section 4 test rule. Summarized in ACC, 2001."},{"key":"atypb29","unstructured":"Monsanto. undated (e): Monsanto report SB-91-9703. Jointly sponsored through the Chemical Manufacturer\u2019s Association as part of a TSCA Section 4 test rule. Summarized in ACC, 2001."},{"key":"atypb30","unstructured":"Monsanto. undated (f): Monsanto report SB-91-9704. Jointly sponsored through the Chemical Manufacturer\u2019s Association as part of a TSCA Section 4 test rule. Summarized in ACC, 2001."},{"key":"atypb31","unstructured":"Monsanto. undated (g): Monsanto report SB-91-9701. Jointly sponsored through the Chemical Manufacturer\u2019s Association as part of a TSCA Section 4 test rule. Summarized in ACC, 2001."},{"key":"atypb32","doi-asserted-by":"publisher","DOI":"10.1002\/em.2850160506"},{"key":"atypb33","series-title":"Technical Report Series","volume-title":"NTP technical report on the toxicology and carcinogenesis studies of 2-mercaptobenzothiazole in F344 rats and B6C3F1 mice (gavage studies)","author":"National Toxicology Program (NTP)","year":"1988"},{"key":"atypb34","volume-title":"Micronucleus test of 2-mercaptobenzothiazole","author":"National Toxicology Program (NTP)","year":"1993"},{"key":"atypb35","volume-title":"NTP historical control information for the NIH-07 diet","author":"National Toxicology Program (NTP)","year":"1999"},{"key":"atypb36","volume-title":"National Occupational Exposure Survey","author":"National Institute of Occupational Safety and Health (NIOSH)","year":"1989"},{"key":"atypb37","volume-title":"Standard 61: Drinking Water System Components-Health Effects","author":"National Sanitation Foundation (NSF)","year":"2003"},{"key":"atypb38","first-page":"44","volume":"107","author":"Ogawa, Y.","year":"1989","journal-title":"Bull Natl Inst Hyg Sci"},{"key":"atypb39","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1974.45"},{"key":"atypb40","first-page":"311","volume-title":"IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans","author":"Peto, R.","year":"1980"},{"key":"atypb41","first-page":"1","volume":"58","author":"Peto, R.","year":"1984","journal-title":"Environmental Health Perspectives"},{"key":"atypb42","volume-title":"Report to the Chemical Manufacturer\u2019s Association","author":"Pharmakon Research","year":"1984"},{"key":"atypb43","volume-title":"Boyd\u2019s textbook of pathology","author":"Ritchie, A. C.","year":"1990"},{"key":"atypb44","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1977.tb03629.x"},{"key":"atypb45","first-page":"998","volume":"50","author":"Sorahan, T.","year":"1993","journal-title":"British Journal of Industrial Medicine"},{"key":"atypb46","doi-asserted-by":"publisher","DOI":"10.1136\/oem.57.2.106"},{"key":"atypb47","unstructured":"Springborn Laboratories. undated: Study No. 3205.5. Jointly sponsored through the Chemical Manufacturer\u2019s Association as part of a TSCA Section 4 test rule. Summarized in ACC, 2001."},{"key":"atypb48","first-page":"369","volume-title":"Pathology of the Fischer rat: reference and atlas","author":"Stefanski, S. A.","year":"1990"},{"key":"atypb49","first-page":"888","volume":"50","author":"Strauss, M. E.","year":"1993","journal-title":"British Journal of Industrial Medicine"},{"key":"atypb50","volume-title":"2-Mercaptobenzothiazole","author":"Toxic Substances Control Act Database (TSCATS)","year":"2003"},{"key":"atypb51","volume-title":"Recommendations for and documentation of biological values for use in risk assessment","author":"US Environmental Protection Agency (US EPA)","year":"1988"},{"key":"atypb52","volume-title":"Draft revised guidelines for carcinogen risk assessment","author":"US Environmental Protection Agency (US EPA)","year":"1999"},{"key":"atypb53","volume-title":"RAGS 3A: process for conducting probabilistic risk assessment. Chapter 1: basic concepts of probabilistic risk assessment","author":"US Environmental Protection Agency (US EPA)","year":"1999"},{"key":"atypb54","volume-title":"Benchmark dose technical guidance manual","author":"US Environmental Protection Agency (US EPA)","year":"2000"},{"key":"atypb55","volume-title":"Methodology for deriving ambient water quality criteria for the protection of human health. Technical support document. Volume 1: risk assessment","author":"US Environmental Protection Agency (US EPA)","year":"2000"},{"key":"atypb56","volume-title":"Draft final guidelines for cancer risk assessment","author":"US Environmental Protection Agency (US EPA)","year":"2003"},{"key":"atypb57","volume-title":"Benchmark dose software","author":"US Environmental Protection Agency (US EPA)","year":"2003"},{"key":"atypb58","volume-title":"Toxicological review for 1,2-dibromoethane. Integrated Risk Information System (IRIS)","author":"US Environmental Protection Agency (US EPA)","year":"2004"},{"key":"atypb59","unstructured":"Williams, T.M., Hickey, J.L.S. and Bishop, C.C. 1984: Health hazard evaluation report No. HETA-83-196-1492. Gadsden, AL: Goodyear Tire and Rubber Company. Hazard Evaluations and Technical Assistance Branch, NIOSH, US Department of Health and Human Services, Cincinnati, OH, Report No. HETA-83-196-1492."},{"key":"atypb60","doi-asserted-by":"publisher","DOI":"10.1248\/jhs1956.37.6"}],"container-title":["Toxicology and Industrial Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1191\/0748233704th199oa","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1191\/0748233704th199oa","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T18:07:36Z","timestamp":1740938856000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1191\/0748233704th199oa"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":60,"journal-issue":{"issue":"6-10","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["10.1191\/0748233704th199oa"],"URL":"https:\/\/doi.org\/10.1191\/0748233704th199oa","relation":{},"ISSN":["0748-2337","1477-0393"],"issn-type":[{"value":"0748-2337","type":"print"},{"value":"1477-0393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7]]}}}